UB Paderborn / Katalog / Suche / in CDI

Overview of Combined Modality Therapies for Head and Neck Cancer

JNCI : Journal of the National Cancer Institute, 1993-01, Vol.85 (2), p.95-111

1993

Volltextzugriff (PDF)

Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck

The New England journal of medicine, 1990-09, Vol.323 (12), p.795-801

1990

Volltextzugriff (PDF)

13-cis-retinoic acid in the treatment of oral leukoplakia

The New England journal of medicine, 1986-12, Vol.315 (24), p.1501

1986

Volltextzugriff (PDF)

Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma

Journal of clinical oncology, 1993-10, Vol.11 (10), p.1919-1928

1993

Volltextzugriff (PDF)

Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity

Annals of oncology, 1997-01, Vol.8 (1), p.85-89

1997

Volltextzugriff (PDF)

Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M. D. Anderson cancer center experience

Head & neck, 1994-01, Vol.16 (1), p.39-44

1994

Volltextzugriff (PDF)

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma

Journal of clinical oncology, 1990-06, Vol.8 (6), p.1056-1062

1990

Volltextzugriff (PDF)

Association of the epstein‐barr virus with lymphoepithelioma of the thymus

Cancer, 1988-06, Vol.61 (12), p.2475-2480

1988

Volltextzugriff (PDF)

A multicenter study of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib plus durvalumab in patients with relapsed/refractory (R/R) solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2578-2578

2018

Volltextzugriff (PDF)

Abstract B42: Ibrutinib in combination with durvalumab (MEDI4736) in patients with relapsed or refractory HER2-positive or triple-negative breast cancer: A phase 1b/2 multicenter study

Molecular cancer research, 2016-02, Vol.14 (2_Supplement), p.B42-B42

2016

Volltextzugriff (PDF)

Ibrutinib + durvalumab (MEDI4736) in patients (pts) with relapsed or refractory (R/R) pancreatic adenocarcinoma (PAC): A phase Ib/II multicenter study

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.TPS484-TPS484

2016

Volltextzugriff (PDF)

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity

Journal of clinical oncology, 1985-10, Vol.3 (10), p.1373-1378

1985

Volltextzugriff (PDF)

A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck

American journal of clinical oncology, 1996-08, Vol.19 (4), p.379-383

1996

Volltextzugriff (PDF)

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck

Journal of clinical oncology, 1991-11, Vol.9 (11), p.1939-1944

1991

Volltextzugriff (PDF)

Improved Therapeutic Index by Leucovorin of Edatrexate, Cyclophosphamide, and Cisplatin Regimen for Non–Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1992-07, Vol.84 (13), p.1039-1040

1992

Volltextzugriff (PDF)

Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck

Journal of clinical oncology, 1988-06, Vol.6 (6), p.955-962

1988

Volltextzugriff (PDF)

Adjuvant chemotherapy for advanced nasopharyngeal carcinoma

Cancer, 1987-09, Vol.60 (5), p.943-949

1987

Volltextzugriff (PDF)

Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx

International journal of radiation oncology, biology, physics, 1988-04, Vol.14 (4), p.623-633

1988

Volltextzugriff (PDF)

Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer

Annals of oncology, 1995-01, Vol.6 (1), p.83-85

1995

Volltextzugriff (PDF)

Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer

Investigational new drugs, 1993-02, Vol.11 (1), p.57-60

1993

Volltextzugriff (PDF)

Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience

The cancer journal from Scientific American, 1997-03, Vol.3 (2), p.92

1997

Volltextzugriff (PDF)

Continuous cisplatin (24‐hour) and 5‐fluorouracil (120‐hour) infusion in recurrent head and neck squamous cell carcinoma

Cancer, 1988-03, Vol.61 (5), p.909-912

1988

Volltextzugriff (PDF)

Phase I/II study of cisplatin, 5-fluorouracil and α-interferon for recurrent carcinoma of the head and neck

Investigational new drugs, 1994-01, Vol.12 (3), p.223-229

1994

Volltextzugriff (PDF)

Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin

Journal of clinical oncology, 1986-11, Vol.4 (11), p.1670-1676

1986

Volltextzugriff (PDF)

Primary oat cell carcinoma of the larynx

American journal of clinical oncology, 1987-02, Vol.10 (1), p.26-32

1987

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Overview of Combined Modality Therapies for Head and Neck Cancer

Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck

13-cis-retinoic acid in the treatment of oral leukoplakia

Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma

Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity

Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M. D. Anderson cancer center experience

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma

Association of the epstein‐barr virus with lymphoepithelioma of the thymus

A multicenter study of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib plus durvalumab in patients with relapsed/refractory (R/R) solid tumors

Abstract B42: Ibrutinib in combination with durvalumab (MEDI4736) in patients with relapsed or refractory HER2-positive or triple-negative breast cancer: A phase 1b/2 multicenter study

Ibrutinib + durvalumab (MEDI4736) in patients (pts) with relapsed or refractory (R/R) pancreatic adenocarcinoma (PAC): A phase Ib/II multicenter study

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity

A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck

Improved Therapeutic Index by Leucovorin of Edatrexate, Cyclophosphamide, and Cisplatin Regimen for Non–Small-Cell Lung Cancer

Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck

Adjuvant chemotherapy for advanced nasopharyngeal carcinoma

Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx

Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer

Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer

Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience

Continuous cisplatin (24‐hour) and 5‐fluorouracil (120‐hour) infusion in recurrent head and neck squamous cell carcinoma

Phase I/II study of cisplatin, 5-fluorouracil and α-interferon for recurrent carcinoma of the head and neck

Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin

Primary oat cell carcinoma of the larynx

Suchergebnisse filtern